Reuters logo
BRIEF-Merck's Glucophage SR receives label extension for patients at high risk of type 2 diabetes in UK
May 17, 2017 / 5:08 PM / 7 months ago

BRIEF-Merck's Glucophage SR receives label extension for patients at high risk of type 2 diabetes in UK

May 17 (Reuters) - Merck & Co Inc:

* Merck’s Glucophage SR receives label extension for patients at high risk of type 2 diabetes in the UK Source text for Eikon: Further company coverage: (Bangalore.newsroom@thomsonreuters.com)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below